Literature DB >> 9693713

Rats receiving the slimming agent oleoyl-estrone in liposomes (Merlin-2) decrease food intake but maintain thermogenesis.

D Sanchis1, F Balada, C Picó, M M Grasa, J Virgili, C Farrerons, A Palou, J A Fernández-López, X Remesar, M Alemany.   

Abstract

Oleoyl-estrone given i.v.--incorporated in liposomes to mimic lipoprotein delivery--(Merlin-2) to normal weight rats, induces a dose-dependent weight loss. Analysis of body composition showed that body protein concentration was preserved and fat stores wasted. The respiratory quotient was consistent with the massive oxidation of body fat, since the diet contained practically no lipid. Appetite was affected by Merlin-2, and thus food intake showed a transient decrease. But oxygen consumption (and basal metabolic rates) was kept practically unchanged at the levels of the controls, i.e. higher than needed to oxidize the food ingested during the weight loss period. Brown adipose tissue uncoupling protein levels were proportionally preserved with a 2-week treatment, but it lost a substantial amount of lipid. In conclusion, Merlin-2 is a slimming agent with considerable potential given its powerful fat-wasting action, since it maintains thermogenesis despite lowered energy intake.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9693713     DOI: 10.1076/apab.105.7.663.11391

Source DB:  PubMed          Journal:  Arch Physiol Biochem        ISSN: 1381-3455            Impact factor:   4.076


  11 in total

1.  Oleoyl-estrone treatment reduces the volume of white adipose tissue cells in the rat.

Authors:  C Cabot; M M Grasa; J A Fernández-López; M Alemany
Journal:  J Physiol Biochem       Date:  2000-12       Impact factor: 4.158

2.  Short-term treatment with estrone oleate in liposomes (Merlin-2) does not affect the expression of the ob gene in Zucker obese rats.

Authors:  C Adán; M M Grasa; C Cabot; M Esteve; R Vilà; R Masanés; J Estruch; J A Fernández-López; X Remesar; M Alemany
Journal:  Mol Cell Biochem       Date:  1999-07       Impact factor: 3.396

Review 3.  Regulation of appetite to treat obesity.

Authors:  Gilbert W Kim; Jieru E Lin; Michael A Valentino; Francheska Colon-Gonzalez; Scott A Waldman
Journal:  Expert Rev Clin Pharmacol       Date:  2011-03       Impact factor: 5.045

Review 4.  Estrogens and Body Weight Regulation in Men.

Authors:  Katya B Rubinow
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

5.  Effect of oleoyl-estrone treatment on the expression of beta1- beta2- and beta3-adrenoreceptors in rat adipose tissues.

Authors:  C Cabot; M del Mar Grasa; J A Fernández-López; M Alemany
Journal:  Mol Cell Biochem       Date:  2001-05       Impact factor: 3.396

6.  Current trends in targeting the hormonal regulation of appetite and energy balance to treat obesity.

Authors:  Michael A Valentino; Francheska Colon-Gonzalez; Jieru E Lin; Scott A Waldman
Journal:  Expert Rev Endocrinol Metab       Date:  2010-09-01

7.  Site-specific modulation of white adipose tissue lipid metabolism by oleoyl-estrone and/or rosiglitazone in overweight rats.

Authors:  R Ferrer-Lorente; C Cabot; J A Fernández-López; M Alemany
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-03-02       Impact factor: 3.000

8.  Comparative effects of oleoyl-estrone and a specific beta3-adrenergic agonist (CL316, 243) on the expression of genes involved in energy metabolism of rat white adipose tissue.

Authors:  Raquel Ferrer-Lorente; Cristina Cabot; José-Antonio Fernández-López; Marià Alemany
Journal:  Nutr Metab (Lond)       Date:  2010-02-25       Impact factor: 4.169

9.  Site-related white adipose tissue lipid-handling response to oleoyl-estrone treatment in overweight male rats.

Authors:  María del Mar Romero; José Antonio Fernández-López; Montserrat Esteve; Marià Alemany
Journal:  Eur J Nutr       Date:  2009-03-27       Impact factor: 5.614

Review 10.  Gut-Brain Endocrine Axes in Weight Regulation and Obesity Pharmacotherapy.

Authors:  Dante J Merlino; Erik S Blomain; Amanda S Aing; Scott A Waldman
Journal:  J Clin Med       Date:  2014-07-15       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.